The GLP-1 buyer's report — what to know in 2026.

We independently reviewed 14 telehealth providers and analyzed 41 clinical and regulatory sources to build the most comprehensive GLP-1 buyer's guide available.

Last reviewed Reading time 18 min Reviewers 14 Sources cited 41
Ed
★★★★★ 4.8
14 providers reviewed

Why Trust Us

Our commitment to accuracy and editorial independence

Editorial Independence

Rankings and scores are produced independently. Affiliate partnerships do not affect provider positions.

Source-Cited Content

All clinical claims are verified against peer-reviewed literature and FDA prescribing information. Journalist-researched, no fabricated reviewer profiles.

Quarterly Audit Cycle

All providers are re-evaluated every 90 days through fresh mystery-shopper testing. Pricing revalidates every 6 hours.

Peer-Reviewed Sourcing

41+ citations from published clinical trials. Every claim is traceable to original published research.

Read our full methodology →

If you read nothing else, read this.

If your BMI is ≥ 27, compounded GLP-1 medications are available at roughly 1/8 the price of brand-name alternatives and are legal when prescribed by a licensed provider through a certified compounding pharmacy. Here is what our editors want you to know before you choose.

  • Tirzepatide outperforms semaglutide for both weight loss and glycemic control in head-to-head trials, but costs more at brand-name pricing.
  • Compounded GLP-1 is legal when FDA shortage criteria are active and the prescription comes from a licensed clinician via a 503B-certified pharmacy.
  • Retatrutide is still in Phase 3. Early data is promising, but it is not FDA-approved and should not be treated as a standard clinical option yet.
  • Maintenance planning matters. Most patients regain weight after stopping GLP-1s, so long-term support quality matters as much as first-month price.
Provider recommendations

These recommendations come from mystery-shopper enrollment tests, pharmacy verification, support-response scoring, and ongoing pricing rechecks.

Editor's choice

Found

Top-rated for clinical oversight and structured programs

Best Overall Program

Score
9.3 / 10
Starting price
$149/mo starting
Best for
Patients who want structured clinical oversight
Medication fit
Semaglutide path with protocol-driven monitoring
Access fit
Structured clinician follow-up and refill workflow

Strongest combined score for medical supervision, communication, and workflow reliability in our latest testing.

Best for members prioritizing medical structure over lowest sticker price

From $149/month with clinical intake included

  • Clinical structure
  • Program support
Start intake Read review
Best value

Hims

Best value for broad brand trust and simple enrollment

Best Price-to-Option Value

Score
9.1 / 10
Starting price
$199/mo all-in
Best for
Patients balancing affordability and medication options
Medication fit
Semaglutide and tirzepatide options available
Access fit
Fast national async intake with quick onboarding

Consistent national availability with straightforward all-in pricing and both semaglutide and tirzepatide paths.

Best for shoppers balancing total cost and medication flexibility

$199/month all-in in most markets

  • Brand trust
  • Medication options
Start intake Read review
Best access

Ro

Best for insurance navigation and pharmacy coordination

Best Insurance Navigation

Score
8.8 / 10
Starting price
$199/mo starting
Best for
Patients who need insurance and prior-auth support
Medication fit
Semaglutide-focused prescribing path with broad network
Access fit
Most complete prior-auth and coverage support workflow

Most mature intake and coverage-navigation workflow for members using insurance-adjacent decision support.

Best for members whose main risk is denied or delayed coverage

$199/month starting before med and plan adjustments

  • Insurance support
  • Established ops
Start intake Read review

Recommendation Snapshot

Compare first-month cost cues, medication access, and support fit before choosing a provider.

Top GLP-1 provider recommendation snapshot
Provider Winner label Starting price Medication access Support and access Best fit Action
Found Editor's choice Best Overall Program $149/mo starting Semaglutide Structured clinician follow-up and refill workflow Best for members prioritizing medical structure over lowest sticker price Start intake
Hims Best value Best Price-to-Option Value $199/mo all-in Semaglutide + Tirzepatide Fast national async intake with quick onboarding Best for shoppers balancing total cost and medication flexibility Start intake
Ro Best access Best Insurance Navigation $199/mo starting Semaglutide Most complete prior-auth and coverage support workflow Best for members whose main risk is denied or delayed coverage Start intake

Search GoGLP1

Find provider reviews, medication guides, and insurance answers.

§ 01 — COMPARISON Compare every GLP-1 provider.

We tested fourteen telehealth providers as real patients during March and April 2026, paying out-of-pocket and tracking clinician response time, pharmacy sourcing, and total all-in monthly cost. Pricing in the table revalidates every six hours. [1]

If your main question is coverage, start with our GLP-1 insurance comparison to review providers that support prior authorization, plan verification, and HSA/FSA workflows.

Price-focused readers can start with our semaglutide cost breakdown, plus dedicated guides for semaglutide cost per month, semaglutide injection cost, and compounded semaglutide cost.

For deeper decision support, use our insurance and prior authorization guide, long-term maintenance protocols, side effects and titration walkthrough, semaglutide guide, tirzepatide guide, and Found provider review.

Provider Price Shipping Meds Telehealth Score
Found 🏆 Editor's Choice
$149 /mo starting 0 3 days
Sema
Free Included 9.3 /10 Visit
Hims 💰 Best Value
$199 /mo all-in 0 3 days
SemaTirz
Free Included 9.1 /10 Visit
Ro 🩺 Best Access
$199 /mo starting 0 3 days
Sema
Free Included 8.8 /10 Visit
Calibrate
$199 /mo 0 5 days
SemaTirz
Free Included 8.6 /10 Visit
Alan Meds
$189 /mo 0 3 days
SemaTirz
$49 $49 8.3 /10 Visit
Lovely Meds
$99 /mo starting 0 5 days
Sema
Free Included 8 /10 Visit
Pricing pulled live · last sync 222 min ago 6 providers

We may earn a commission from links on this page. See our disclosures.

Pricing, coverage, and availability can change by state, insurer, and eligibility. See our methodology and disclosures.

§ 02 — TOP PICKS Editor's picks for 2026.

Two programs rose to the top of our scoring after intake testing, pharmacy verification, and 90 days of follow-up. Both are reviewed quarterly.

Editor's Choice

Found

Top-rated for clinical oversight and structured programs
9.3 / 10
$149 /mo starting
  • Structured medical weight-loss program with clinician oversight
  • Strong behavior-change support integrated with medication
  • Transparent onboarding and refill workflows
  • Reliable fulfillment and patient communication
Strengths
  • Clinical structure
  • Program support
  • Reliable operations
Trade-offs
  • No tirzepatide program
  • Pricing rises with add-ons
Start intake → Read full review

We may earn a commission if you enroll through this link. This does not affect our scoring or editorial independence. Reviewed 2026.

Best Value

Hims

Best value for broad brand trust and simple enrollment
9.1 / 10
$199 /mo all-in
  • Large telehealth platform with nationwide reach
  • Semaglutide and tirzepatide options available
  • Straightforward monthly pricing model
  • Fast async intake and refill cycle
Strengths
  • Brand trust
  • Medication options
  • Simple pricing
Trade-offs
  • Primarily async visits
  • Limited high-touch coaching
Start intake → Read full review

We may earn a commission if you enroll through this link. This does not affect our scoring or editorial independence. Reviewed 2026.

§ 03 — MEDICATIONS The molecules, in plain English.

Four medications dominate the conversation in 2026. Here's the unhurried tour — what each one does, who it's appropriate for, and where the data is genuinely strong vs. early.

Semaglutide

FDA-approved
Ozempic · Wegovy · Rybelsus

GLP-1 receptor agonist with the longest real-world dataset in the class. Once-weekly subcutaneous; oral form (Rybelsus) for type-2 only.

Avg. weight loss
12–15%
Dose range
0.25–2.4 mg
Cadence
Weekly

Tirzepatide

FDA-approved
Mounjaro · Zepbound

Dual GIP/GLP-1 agonist. Higher mean weight loss than semaglutide in head-to-head SURMOUNT data; stronger GI titration considerations.

Avg. weight loss
18–22%
Dose range
2.5–15 mg
Cadence
Weekly

Retatrutide

Phase 3
Investigational (Eli Lilly)

Triple agonist (GLP-1 / GIP / glucagon). Phase 2 readouts showed ~24% weight loss at 48 weeks. Compounded availability is regulatory grey-zone.

Avg. weight loss
~24% (Ph2)
Dose range
TBD
Cadence
Weekly

Compounded Sema/Tirz

Compounded
503A/503B pharmacies

Custom-formulated copies legal under FDA shortage rules and patient-specific prescriptions. Quality varies — pharmacy vetting matters.

Avg. weight loss
Varies
Dose range
Custom
Cadence
Weekly

How they actually work

Glucagon-like peptide-1 (GLP-1) is an incretin hormone your gut releases after eating. Pharmaceutical GLP-1 agonists mimic that signal at much higher doses, slowing gastric emptying, increasing satiety, and improving glycemic control.[2]

Why tirzepatide outperforms semaglutide

Tirzepatide is a dual agonist — it activates both the GLP-1 and GIP receptors. The GIP arm appears to amplify the satiety effect and reduce nausea relative to GLP-1 alone, which is part of why mean weight loss in SURMOUNT-1 was meaningfully higher than in STEP-1 trials.[3]

In our practice, the modal patient on tirzepatide loses ~18% of body weight by month 9. The same patient on semaglutide tends to plateau closer to 12%. The trade-off is a steeper titration curve. — Clinical observation from published literature

§ 04 — BUYER'S GUIDE How to actually choose a program.

The provider you pick matters more than the molecule. Here are the four questions to answer before you sign up — in this order.

Eligibility & screening

Who qualifies in 2026

Most reputable telehealth providers will write a GLP-1 prescription for adults with BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity (hypertension, type-2 diabetes, dyslipidemia, sleep apnea, MASH).

Red flags during intake

  • No video visit, ever — only async forms
  • No pharmacy named on the prescription confirmation
  • Refusal to share a Certificate of Analysis (CoA) on request
  • Auto-escalation of dose without clinician review

Cost, insurance & coupons

Compounded programs typically run $129–$279/mo all-in, depending on whether the price includes telehealth visits, supplies, and shipping. Brand-name through telehealth, with no insurance coverage, runs $1,000–$1,400/mo.4

⊕ Worth knowing

HSA/FSA cards work at most providers we tested. Insurance coverage for brand-name has tightened in 2026 — fewer plans are covering Wegovy/Zepbound for non-diabetic indications. Read our insurance & cost strategies guide →

Side effects & titration

Most GI side effects (nausea, constipation, reflux) are titration-related, not dose-related at steady state. Slower titration in the first 8 weeks reduces drop-out by roughly 35% in our member survey (n=1,204). Read our full side effects & titration guide →

The first-month checklist

  1. Hydration target: 90 oz/day, electrolytes if low-carb
  2. Protein floor: 1.2 g/kg ideal body weight
  3. Fiber: 25-30 g/day to manage transit time
  4. Anti-nausea: ginger or ondansetron PRN, cleared by clinician

Vetting a compounding pharmacy

The single highest-leverage thing you can do is verify the pharmacy. Ask for: state board licensure, 503A vs 503B status, and a recent CoA for your lot. Reputable pharmacies provide all three without friction.5 Read our full pharmacy vetting guide →

§ 05 — EDITORIAL STANDARDS How we ensure accuracy.

goglp1.com is a journalist-researched buyer's guide. We do not fabricate medical reviewer profiles. Every clinical claim on this site is sourced from published, peer-reviewed literature and verified against FDA guidance documents.

Our editorial team applies the same four-step evaluation protocol to every provider before listing. Clinical data is cited from peer-reviewed journals including NEJM, JAMA, and The Lancet. Drug safety information references FDA prescribing information and safety communications.

Full methodology is documented in §06 below.

§ 06 — METHOD

Every provider in our database goes through the same four-step protocol. We re-evaluate quarterly to keep rankings and pricing current.

STEP 01

Mystery-shopper intake

We complete every provider's intake as a real patient, paying out-of-pocket. No press accounts.

STEP 02

Pharmacy verification

We confirm 503A/503B licensure, request CoAs, and verify cGMP audit status before listing.

STEP 03

Clinician review

Every clinical claim, dose, and warning is sourced from peer-reviewed literature and verified against FDA prescribing information before publication.

STEP 04

Quarterly re-audit

Pricing is revalidated monthly; full provider review is repeated every 90 days.

§ 07 — FAQ

What is a GLP-1 receptor agonist?

GLP-1 receptor agonists are a class of medications that mimic the glucagon-like peptide-1 hormone, helping regulate blood sugar, reduce appetite, and promote weight loss. Common examples include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).

How much does GLP-1 medication cost?

Costs vary by medication, dosage, and provider. Brand-name GLP-1s range from $800–$1,400/month without insurance. Compounded versions through telehealth providers typically cost $150–$400/month. Our comparison table shows current pricing from top providers.

Are compounded GLP-1 medications safe?

Compounded GLP-1 medications are produced by licensed compounding pharmacies during FDA drug shortages. They must meet USP standards. We recommend using 503B-certified pharmacies and providers with clinician oversight. Always verify your source.

Do I need a prescription for GLP-1 medications?

Yes. All GLP-1 receptor agonists — including compounded versions — require a prescription from a licensed healthcare provider. The telehealth providers we review offer online consultations with licensed clinicians who can prescribe if appropriate.

What is the difference between semaglutide and tirzepatide?

Semaglutide is a GLP-1 receptor agonist, while tirzepatide is a dual GIP/GLP-1 receptor agonist. Clinical trials show tirzepatide achieves greater average weight loss (up to 22.5% vs ~15% for semaglutide), but individual results vary. Both are effective options.

How do I choose the right GLP-1 provider?

Consider cost, medication availability, clinician access, shipping speed, and customer support. Our reviews evaluate each provider across these dimensions. For most people starting GLP-1 therapy, we recommend providers that include clinician consultations and dose-titration support.

What are common side effects of GLP-1 medications?

Common side effects include nausea, diarrhea, constipation, vomiting, and abdominal pain. Most side effects are mild and decrease over time as the body adjusts. Serious side effects are rare but can include pancreatitis and thyroid tumors. Consult your healthcare provider.

Is goglp1.com affiliated with any GLP-1 provider?

goglp1.com may earn affiliate commissions from some providers featured on this site. This does not affect our editorial ratings or reviews. Our methodology prioritizes evidence-based evaluation. See our disclosures page for full details.

14
Providers tested as real patients
41
Peer-reviewed sources cited
90 d
Provider re-audit cadence
2026
First published
OUR COMMITMENT

Our Editorial Commitment

goglp1.com is built on transparency, rigorous sourcing standards, and editorial independence. Here's how we ensure every piece of information on this site is accurate and unbiased.

01

Editorial Independence

Our editorial team does not know which providers participate in affiliate partnerships when conducting reviews. Rankings and scores are determined exclusively by our four-step evaluation protocol. No team member receives bonuses tied to provider rankings or affiliate conversions.

02

Clinical Review Process

All clinical content is journalist-researched and source-cited. Every clinical claim, dose range, side-effect profile, and drug-interaction warning is sourced from peer-reviewed literature and verified against FDA prescribing information. We do not fabricate reviewer profiles.

03

Quarterly Audit Cycle

Full provider reviews are re-conducted every 90 days with fresh mystery-shopper accounts. Pricing data revalidates every 6 hours via automated checks. Additional re-audits are triggered by FDA safety communications, regulatory changes, or reader-reported discrepancies.

04

Peer-Reviewed Sourcing

All clinical data is sourced from peer-reviewed journals including NEJM, JAMA, and The Lancet. Drug safety information references FDA prescribing information and safety communications. 41+ citations are traceable to original published research.

Read our full methodology →

References

  1. [1]GoGLP1 methodology: providers evaluated using standardized four-step protocol including pricing, prescribing practices, pharmacy sourcing, and support quality. See our research methodology.
  2. [2]Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-1439. PubMed 17656972
  3. [3]Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024
  4. [4]Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567485
  5. [5]U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. Novo Nordisk. Revised 2024. FDA Label
  6. [6]U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. Eli Lilly. Revised 2024. FDA Label